Search by Drug Name or NDC

    NDC 16571-0843-50 POTASSIUM CHLORIDE EXTENDED RELEASE 750 mg/1 Details

    POTASSIUM CHLORIDE EXTENDED RELEASE 750 mg/1

    POTASSIUM CHLORIDE EXTENDED RELEASE is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Rising Pharma Holdings, Inc.. The primary component is POTASSIUM CHLORIDE.

    Product Information

    NDC 16571-0843
    Product ID 16571-843_fe4e9cca-4035-4f2a-8802-ce569e2af05e
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name POTASSIUM CHLORIDE EXTENDED RELEASE
    Proprietary Name Suffix n/a
    Non-Proprietary Name potassium chloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 750
    Active Ingredient Units mg/1
    Substance Name POTASSIUM CHLORIDE
    Labeler Name Rising Pharma Holdings, Inc.
    Pharmaceutical Class Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA217412
    Listing Certified Through 2024-12-31

    Package

    NDC 16571-0843-50 (16571084350)

    NDC Package Code 16571-843-50
    Billing NDC 16571084350
    Package 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-843-50)
    Marketing Start Date 2023-12-19
    NDC Exclude Flag N
    Pricing Information N/A